Process View
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of neuron projection development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HDAC2 | histone deacetylase 2 | 1.000 | Mouse Fly | |
| HDAC1 | histone deacetylase 1 | 0.999 | Fly | |
| FGF1 | fibroblast growth factor 1 (acidic) | 0.786 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.585 | ||
| TTR | transthyretin | 0.405 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.255 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.255 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.219 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.192 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.178 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.176 | Fly | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.148 | ||
| TEX11 | testis expressed 11 | 0.130 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.125 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.113 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.112 | ||
| VEGFA | vascular endothelial growth factor A | 0.107 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.105 | ||
| RBBP7 | retinoblastoma binding protein 7 | 0.100 | ||
| CPE | carboxypeptidase E | 0.087 | ||
| A2M | alpha-2-macroglobulin | 0.084 | ||
| RAB5A | RAB5A, member RAS oncogene family | 0.081 | ||
| ATG13 | ATG13 autophagy related 13 homolog (S. cerevisiae) | 0.072 | ||
| CHDH | choline dehydrogenase | 0.072 | ||
| GET4 | golgi to ER traffic protein 4 homolog (S. cerevisiae) | 0.071 | ||
| NDEL1 | nudE nuclear distribution gene E homolog (A. nidulans)-like 1 | 0.071 | ||
| MTA1 | metastasis associated 1 | 0.067 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.066 | Fly | |
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.058 | ||
| COL4A3BP | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | 0.053 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.052 | ||
| NGFR | nerve growth factor receptor | 0.051 | Rat | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.051 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.051 | ||
| CYFIP2 | cytoplasmic FMR1 interacting protein 2 | 0.046 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.043 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.042 | ||
| STMN2 | stathmin-like 2 | 0.041 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.041 | ||
| C17orf28 | chromosome 17 open reading frame 28 | 0.038 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.037 | ||
| ATN1 | atrophin 1 | 0.037 | ||
| GOLGA2 | golgin A2 | 0.035 | ||
| FAM160A2 | family with sequence similarity 160, member A2 | 0.035 | ||
| SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 0.035 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.035 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.033 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.032 | ||
| NEGR1 | neuronal growth regulator 1 | 0.032 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.031 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.030 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.030 | ||
| MAP1S | microtubule-associated protein 1S | 0.028 | ||
| ALK | anaplastic lymphoma receptor tyrosine kinase | 0.028 | ||
| TAF1D | TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa | 0.027 | ||
| JAG2 | jagged 2 | 0.027 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.026 | ||
| CCDC85A | coiled-coil domain containing 85A | 0.026 | ||
| DCC | deleted in colorectal carcinoma | 0.025 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.024 | ||
| GABARAP | GABA(A) receptor-associated protein | 0.024 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.024 | ||
| EPOR | erythropoietin receptor | 0.024 | ||
| NCSTN | nicastrin | 0.024 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.023 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.023 | ||
| ALB | albumin | 0.023 | ||
| RXRA | retinoid X receptor, alpha | 0.022 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.021 | ||
| MYO6 | myosin VI | 0.021 | ||
| MBD2 | methyl-CpG binding domain protein 2 | 0.021 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.021 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.021 | Fly | |
| CTGF | connective tissue growth factor | 0.021 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.021 | ||
| RTN4 | reticulon 4 | 0.020 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.020 | ||
| CYFIP1 | cytoplasmic FMR1 interacting protein 1 | 0.020 | ||
| SPOP | speckle-type POZ protein | 0.019 | ||
| FGF10 | fibroblast growth factor 10 | 0.019 | ||
| CHD4 | chromodomain helicase DNA binding protein 4 | 0.019 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.019 | ||
| RCOR1 | REST corepressor 1 | 0.019 | ||
| APP | amyloid beta (A4) precursor protein | 0.019 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.019 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.019 | ||
| LCMT1 | leucine carboxyl methyltransferase 1 | 0.019 | ||
| SETDB1 | SET domain, bifurcated 1 | 0.019 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.019 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.018 | ||
| NELL2 | NEL-like 2 (chicken) | 0.018 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.018 | ||
| PKP4 | plakophilin 4 | 0.017 | ||
| LUC7L2 | LUC7-like 2 (S. cerevisiae) | 0.016 | ||
| GANAB | glucosidase, alpha; neutral AB | 0.016 | ||
| SAP30 | Sin3A-associated protein, 30kDa | 0.016 | ||
| RAP1A | RAP1A, member of RAS oncogene family | 0.016 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.016 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.016 | ||
| TSC22D4 | TSC22 domain family, member 4 | 0.015 | ||
| HMG20B | high mobility group 20B | 0.015 | ||
| JAK3 | Janus kinase 3 | 0.015 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.015 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.015 | ||
| CLIP1 | CAP-GLY domain containing linker protein 1 | 0.015 | ||
| SESN2 | sestrin 2 | 0.015 | ||
| FLNB | filamin B, beta | 0.015 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.015 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.014 | ||
| RB1CC1 | RB1-inducible coiled-coil 1 | 0.014 | ||
| FAM118B | family with sequence similarity 118, member B | 0.014 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.014 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.014 | ||
| MAPK11 | mitogen-activated protein kinase 11 | 0.014 | ||
| HP | haptoglobin | 0.014 | ||
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.013 | ||
| RUNDC3A | RUN domain containing 3A | 0.013 | ||
| UBE2G1 | ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, yeast) | 0.013 | ||
| KCNRG | potassium channel regulator | 0.013 | ||
| BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0.013 | Human | |
| PRKD2 | protein kinase D2 | 0.013 | ||
| LAPTM4A | lysosomal protein transmembrane 4 alpha | 0.013 | ||
| EZH2 | enhancer of zeste homolog 2 (Drosophila) | 0.013 | ||
| ATG9A | ATG9 autophagy related 9 homolog A (S. cerevisiae) | 0.013 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.013 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.012 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.012 | ||
| HSF2 | heat shock transcription factor 2 | 0.012 | ||
| NONO | non-POU domain containing, octamer-binding | 0.012 | ||
| THY1 | Thy-1 cell surface antigen | 0.012 | Rat | |
| BGN | biglycan | 0.012 | ||
| PXN | paxillin | 0.012 | ||
| ANAPC7 | anaphase promoting complex subunit 7 | 0.012 | ||
| MAPT | microtubule-associated protein tau | 0.012 | ||
| PTN | pleiotrophin | 0.012 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.012 | ||
| CDYL | chromodomain protein, Y-like | 0.011 | ||
| RBP4 | retinol binding protein 4, plasma | 0.011 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.011 | ||
| IMMT | inner membrane protein, mitochondrial | 0.011 | ||
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.011 | ||
| STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0.011 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.011 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.011 | ||
| HDAC3 | histone deacetylase 3 | 0.011 | ||
| EFS | embryonal Fyn-associated substrate | 0.011 | ||
| CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 0.011 | ||
| GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.010 | ||
| FIBP | fibroblast growth factor (acidic) intracellular binding protein | 0.010 | ||
| KIAA0408 | KIAA0408 | 0.010 | ||
| PSEN1 | presenilin 1 | 0.010 | Mouse | |
| BMI1 | BMI1 polycomb ring finger oncogene | 0.010 | ||
| FBLN1 | fibulin 1 | 0.010 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.010 |